AI Article Synopsis
- The study aims to evaluate the variability in measurements of atherosclerotic plaque (ASP) area and height in carotid arteries, proposing these as potential indicators for assessing the effectiveness of secondary prevention after acute coronary syndrome (ACS).
- Analysis was conducted on patients with confirmed ACS and recorded ASP, revealing that variability in measurements between different studies was notably higher than that within the same study, indicating inconsistencies in data collection or methodology.
- Although some changes in ASP parameters were observed over a six-month follow-up, the differences were not statistically significant, highlighting the need for improved protocols and training for the specialists involved in these evaluations.
Article Abstract
Aim Analysis of inter- and intra-study variability of changes in the atherosclerotic plaque (ASP) total height and total area, the main quantitative indexes that were planned to be used in the present study for assessment of the atherosclerotic load of carotid arteries.Material and methods The incidence of recurrent cardiovascular complications (CVC) within 1 year after acute coronary syndrome (ACS) ranges from 7-9 % (in studies) to 34 % (in clinical practice). This indicates insufficient efficacy of traditional approaches to secondary prevention of coronary heart disease. We proposed a study to test a hypothesis that the dynamics of ASP parameters in carotid and subclavian regions can serve as an alternative criterion for the adequacy of secondary prevention after ACS. The analysis was performed on subgroups of main study participants. These patients had ACS of any type documented by coronary angiography with an ASP confirmed by ultrasound of the brachiocephalic arteries (BCA) during the index hospitalization. BCA ultrasound was performed to analyze the inter- and intra-study variability of BCA atherosclerotic load, the ASP total height (Hsum) and total area (ASPTA), in 20 and 24 patients of the main study, respectively. Results of the repeated ultrasound were evaluated in 30 patients of the main study after 6 months of follow-up.Results The inter-study variability of each index was significantly higher than the intra-study variability which was consistent with results of previous studies. The intra-study variability of Hsum was 0.10 (95 % confidence interval, CI - 0.23-0.44) mm and ASPTA, 1.05 (95 % CI, - 0.54-2.63) mm2. The variability values were considerably smaller than the changes for 6 months: Hsum, 0.92 (95 % CI, - 0.64-2.49) mm and ASPTA, 3.67 (95 % CI, 0.42-6.91) mm2, although the difference did not reach statistical significance. The above results were obtained at an early stage of the study during the adaptation of specialists to the protocol.Conclusion The study results suggest a possibility of a fairly reliable assessment of the dynamics of quantitative indexes of carotid ultrasound 6 months after ACS.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.18087/cardio.2023.9.n2460 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Conventional High-Dose vs Low-Dose Hyaluronidase for Skin Necrosis after Hyaluronic Acid Fillers: A Systematic Review and Pilot Meta-Analysis.
Aesthetic Plast Surg
October 2024
Department of Plastic and Reconstructive Surgery, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Article Synopsis
- Hyaluronidase is the primary treatment for skin necrosis caused by vascular occlusion after hyaluronic acid fillers, but there’s a lack of strong evidence on the best dosages to use.
- A systematic review and pilot meta-analysis of 15 studies found that 77.8% of patients saw complete resolution of scars after treatment, with low doses showing a higher success rate (88.1%) compared to high doses (69.6%), although the difference was not statistically significant.
- The study suggests that future research should focus on providing detailed protocols to create evidence-based guidelines for using hyaluronidase in clinical settings.
Comparative Study of Dermal Pharmacokinetics Between Topical Drugs Using Open Flow Microperfusion in a Pig Model.
Pharm Res
February 2024
HEALTH - Institute for Biomedical Research and Technologies, Joanneum Research Forschungsgesellschaft M.B.H, Neue Stiftingtalstrasse 2, 8010, Graz, Austria.
Purpose: Accurate methods to determine dermal pharmacokinetics are important to increase the rate of clinical success in topical drug development. We investigated in an in vivo pig model whether the unbound drug concentration in the interstitial fluid as determined by dermal open flow microperfusion (dOFM) is a more reliable measure of dermal exposure compared to dermal biopsies for seven prescription or investigational drugs. In addition, we verified standard dOFM measurement using a recirculation approach and compared dosing frequencies (QD versus BID) and dose strengths (high versus low drug concentrations).
View Article and Find Full Text PDFAre changes in vitellogenin concentrations in fish reliable indicators of chemical-induced endocrine activity?
Ecotoxicol Environ Saf
November 2023
Bayer AG, R&D, Crop Science Division, Environmental Safety, Alfred-Nobel Strasse 50, 40789 Monheim am Rhein, Germany.
Vitellogenin (VTG), a biomarker for endocrine activity, is a mechanistic component of the regulatory assessment of potential endocrine-disrupting properties of chemicals. This review of VTG data is based on changes reported for 106 substances in standard fish species. High intra-study and inter-laboratory variability in VTG concentrations was confirmed, as well as discrepancies in interpretation of results based on large differences between fish in the dilution water versus solvent control, or due to the presence of outlier measurements.
View Article and Find Full Text PDFArticle Synopsis
- The study aims to evaluate the variability in measurements of atherosclerotic plaque (ASP) area and height in carotid arteries, proposing these as potential indicators for assessing the effectiveness of secondary prevention after acute coronary syndrome (ACS).
- Analysis was conducted on patients with confirmed ACS and recorded ASP, revealing that variability in measurements between different studies was notably higher than that within the same study, indicating inconsistencies in data collection or methodology.
- Although some changes in ASP parameters were observed over a six-month follow-up, the differences were not statistically significant, highlighting the need for improved protocols and training for the specialists involved in these evaluations.
Standardized tissue sampling guidelines for histopathological and molecular analyses of rainbow trout (Oncorhynchus mykiss) in ecotoxicological studies.
PLoS One
July 2023
Institute of Veterinary Pathology at the Center for Clinical Veterinary Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
In ecotoxicology, evaluation of toxicities and no observed effect concentrations (NOEC) of test compounds in experimental fish is commonly based on molecular-, biochemical- and analytical chemistry analyses of organ/tissue samples and the assessment of (histo-) pathological lesions. Standardization of organ/tissue sampling locations, sample numbers, and sample processing contributes to warrant the reproducibility and inter- and intra-study comparability of analysis results. The present article provides the first comprehensive tissue sampling guidelines specifically adapted to rainbow trout (Oncorhynchus mykiss) as a frequently used fish species in ecotoxicological studies.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!